Cargando…
Correction: Correlation between cognition and plasma noradrenaline level in Alzheimer’s disease: a potential new blood marker of disease evolution
Autores principales: | Pillet, Laure-Elise, Taccola, Camille, Cotoni, Justine, Thiriez, Hervé, André, Karine, Verpillot, Romain |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687902/ https://www.ncbi.nlm.nih.gov/pubmed/33235192 http://dx.doi.org/10.1038/s41398-020-01102-y |
Ejemplares similares
-
Correlation between cognition and plasma noradrenaline level in Alzheimer’s disease: a potential new blood marker of disease evolution
por: Pillet, Laure-Elise, et al.
Publicado: (2020) -
Noradrenaline in Alzheimer’s Disease: A New Potential Therapeutic Target
por: Gutiérrez, Irene L., et al.
Publicado: (2022) -
Noradrenaline and Parkinson's Disease
por: Delaville, Claire, et al.
Publicado: (2011) -
The Contribution of the Locus Coeruleus–Noradrenaline System Degeneration during the Progression of Alzheimer’s Disease
por: Mercan, Dilek, et al.
Publicado: (2022) -
Noradrenaline and Movement Initiation Disorders in Parkinson’s Disease: A Pharmacological Functional MRI Study with Clonidine
por: Criaud, Marion, et al.
Publicado: (2022)